Clinical Trial Update: Food Trial Evaluating Fecal Abundance of SBD111 With Once-Daily Versus Twice-Daily Administration in Healthy Adults [NA]

View source ↗

Summary

Solarea Bio is testing the probiotic SBD111 in healthy adults to compare once-daily versus twice-daily dosing; the study relates to osteopenia/osteoporosis cont…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Osteopenia
• Osteoporosis

Drugs mentioned

• SBD111

Snippet

Sponsor: Solarea Bio, Inc | Conditions: Osteopenia, Osteoporosis | NA | Status: NOT_YET_RECRUITING